Telmikaa (Telmisartan) is a nonpeptide angiotensin II receptor (type AT1) antagonist. Telmisartan is insoluble in water and hence the rate of dissolution & its bioavailability is less. Therefore, formulating optimum bioavailable telmisartan is a challenge. Telmikaa is manufactured by Maxisorb Technology which significantly enhances the absorption of telmisartan, transforming it into optimum bioavailable formulation. The company has applied for a process patent.

Thus, Telmikaa 20, 40, 80 & Telmikaa H assures superior pharmacokinetic profile, as compared to the leading Indian brand. This has been established by appropriate pharmacokinetic studies. Needless to say, Telmikaa is bio-equivalent to the innovator brand.

That's why Telmikaa is not just another telmisartan, it is the only optimum bioavailable Telmisartan in India. Telmikaa promises superior outcome in B.P. management.

Indication: Telmikaa (telmisartan) is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

Telmisartan & hydrochlorothiazide combination is indicated for the treatment of hypertension. This fixed dose combination is not indicated for initial therapy.

Features:
1. Telmikaa is bioequivalent to innovator brand Micardis.
2. Telmikaa offers;

(i) More pronounced B.P. control.
(ii) Less need for higher dose.
(iii) Less need for combination therapy.

Presentation: Telmikaa 20, 40, 80 & H (Along with HCTZ)